dr. jackman on overcoming resistance to egfr inhibitors in lung cancer
Published 7 years ago • 82 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
5:46
resistance mechanisms in egfr nsclc
-
4:32
resistance mechanisms in egfr-positive nsclc
-
3:48
mechanisms of resistance to upfront egfr-targeted therapy
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
6:12
resistance in egfr-mutant lung cancer
-
2:20
dr. liu on resistance mechanisms in egfr-mutant lung cancer
-
3:28
emerging egfr inhibitors in nsclc
-
24:58
strategies to prevent and overcome resistance to egfr-directed therapies in lung cancer
-
1:44
dr. oxnard on delaying second-line treatment in egfr-mutant lung cancer
-
1:16
dr. goldberg on options after developing resistance to osimertinib for nsclc
-
8:31
resistance mechanisms and sequencing for egfr nsclc
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
1:27
dr. wakelee discusses egfr tkis in lung cancer
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
1:29
dr. lynch on targeting egfr mutation subtypes in lung cancer
-
9:39
emerging therapies in egfr-positive nsclc
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer